| Line item | 2025-08-31 FY | 2024-08-31 FY | 2023-08-31 FY | 2022-08-31 FY | 2021-08-31 FY |
|---|---|---|---|---|---|
| Revenue | – | – | – | – | – |
| Cost of Revenue | – | – | – | – | – |
| Gross Profit | – | – | – | – | – |
| Operating Expenses | $1.21M | $953.60K | $2.60M | $2.91M | $1.56M |
| R&D | – | – | – | – | – |
| SG&A | $871.71K | $877.28K | $1.82M | $1.38M | $1.34M |
| Operating Income | -$1.21M | -$953.60K | -$2.60M | -$2.91M | -$1.56M |
| Interest Expense | – | – | – | – | – |
| Tax Expense | – | – | – | – | – |
| Net Income | -$1.93M | -$833.01K | -$2.59M | -$2.90M | $2.04M |
| EPS (basic) | -0.0300 | -0.0100 | -0.0400 | -0.0400 | 0.0300 |
| EPS (diluted) | -0.0300 | -0.0100 | -0.0400 | -0.0400 | 0.0300 |
| Shares (diluted) | $75.00M | $73.93M | $73.20M | $72.40M | $72.86M |